Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(20): 1060
DOI: 10.1055/s-0029-1222568
DOI: 10.1055/s-0029-1222568
Pro & Contra | Commentary
Diabetologie, Endokrinologie
© Georg Thieme Verlag KG Stuttgart · New York
Intensive Blutglukosesenkung zur Reduktion des kardiovaskulären Risikos: pro
Intensive glucose lowering to reduce cardiovascular risk: proFurther Information
Publication History
Publication Date:
06 May 2009 (online)

Schlüsselwörter
Blutglukosesenkung - kardiovaskuläres Risiko
Keywords
blood glucose control - cardiovascular risk
Literatur
- 1 Action to Control Cardiovascular Risk in Diabetes Study Group . Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358 2545-2559
- 2 ADVANCE Collaborative Group . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358 2560-2572
- 3 Gaede P, Lund-Andersen H, Parving H H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358 580-591
- 4 Holman R R, Paul S K, Bethel M A, Matthews D R, Neil H A. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. 2008; 359 1577-1589
- 5 Holman R R, Paul S K, Bethel M A, Neil H A, Matthews D R. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008; 359 1565-1576
- 6 UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352 837-853
Prof. Dr. Stephan Martin
Ärztlicher Direktor, Westdeutsches
Diabetes- und Gesundheitszentrum, Sana Kliniken Düsseldorf
GmbH, Sana Krankenhaus Gerresheim
Gräulinger
Str. 120
40625 Düsseldorf
Phone: 0211/2800-3960/-1
Fax: 0211/2800-3962
Email: S.Martin@sana-duesseldorf.de